Biopharmaceutical Company
FY 2018 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. government.  FY 2019 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. government. Re-authorization of the Pandemic and All-Hazards Preparedness Act.  NDAA - provisions related to biological and chemical defense. FY 2018 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. government.  FY 2019 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. government. Re-authorization of the Pandemic and All-Hazards Preparedness Act.  NDAA - provisions related to biological and chemical defense. FY 2018 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. government.  FY 2019 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. government.  Re-authorization of the Pandemic and All-Hazards Preparedness Act.  NDAA - provisions related to biological and chemical defense.
DIS - Disaster Planning/Emergencies BUD - Budget/Appropriations HOM - Homeland Security
DAVIS & HARMAN LLP
1455 Pennsylvania Avenue, N. W., Suite 1200, Washington, DC, 20004, US
THOMAS A DAVIS THOMAS A DAVIS THOMAS A DAVIS